Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Tips for that discussion with patients from Lowell Schnipper, MD → Read More
Specialists concerned it will complicate discussions with patients → Read More
Policy experts discuss initiative from Amazon, Berkshire Hathaway, and JPMorgan Chase → Read More
Experts respond to recent study implicating repetitive small blows to the head → Read More
Tips for showing high up in searches without paying → Read More
Communications expert Ron Harman King examines the legal and practical questions → Read More
Apologizing doesn't guarantee losing a malpractice suit -- but it might prevent one → Read More
The extensive news coverage of the Las Vegas shooter has focused heavily on his motivation. But a leading psychiatrist says we should be "thinking ahead to the mass-shooters in waiting -- the copycats -- who will use the Las Vegas murders as a template for their own horrific schemes." Ronald Pies, MD, editor emeritus of Psychiatric Times, wrote that media publicity will provide motivation for… → Read More
In Japan it's called 'Karoshi' - death from overwork. → Read More
Three physicians share the ways in which their lives were forever changed by gunmen → Read More
In our series on "The Wired Practice," Ron Harman King of Vanguard Communications has looked at how to create a website and what to do about negative online reviews. In this video King discusses why physicians should blog and how often they should do it. → Read More
How often do patients turn to online reviews of doctors? Can you ignore online reviews? How should you respond? In our "Wired Practice" video Ron Harman King of Vanguard Communications discusses those questions. last updated 01.04.2017 → Read More
Video provides views from tobacco, public health, and regulation experts → Read More
High fitness level associated with lower mortality throughout the first year post MI → Read More
Study found mortality risk with adaptive servo-ventilation → Read More
Novartis heart failure drug cited as 'breakthrough' → Read More
The approval of the new class of cholesterol lowering drug -- the PCSK9 inhibitors -- was one of the five biggest clinical advances in cardiology in 2015, according to leading cardiologists. Alirocumab (Praluent) and evolocumab (Repatha) were approved in July and August, respectively, for statin intolerant and insufficient patients. This includes patients who fail to achieve LDL cholesterol… → Read More
Ocrelizumab trials show benefit for both relapsing and progressive forms → Read More
A massive federally-funded trial that found lives can be saved with aggressive lowering of systolic blood pressure -- the SPRINT trial -- was the top game-changer in cardiology in 2015 among cardiologists contacted by MedPage Today. Here are the top five game-changers: 1. SPRINT 2. PCSK9 inhibitors approval 3. Entresto approval 4. EMPA-REG 5. Interventional (ABSORB III, TAVR) Cardiologists who… → Read More
November's terrorist attacks in Paris -- in which a coordinated series of bombings and shootings occurred in multiple locations around the city -- raise the critical question of whether U.S. cities are prepared to treat hundreds of victims with serious war-type injuries at multiple hospitals. Leaders of the 40-hospital consortium in Paris that managed the city's medical response boasted… → Read More